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ABSTRACT
Background. Although Mycobacterium tuberculosis (Mtb) strains exhibit genomic
homology of >99%, there is considerable variation in the phenotype. The underlying
mechanisms of phenotypic heterogeneity inMtb are not well understood but epigenetic
variation is thought to contribute. At present the methylome of Mtb has not been
completely characterized.
Methods. We completed methylomes of 18 Mycobacterium tuberculosis (Mtb) clinical
isolates fromMalawi representing the largest number ofMtb genomes to be completed
in a single study using Single Molecule Real Time (SMRT) sequencing to date.
Results. We replicate and confirm four methylation disrupting mutations in 4 lineages
of Mtb. For the first time we report complete loss of methylation courtesy of C758T
(S253L) mutation in the MamB gene of Indo-oceanic lineage of Mtb. Additionally,
we report a novel missense mutation G454A (G152S) in the MamA gene of the
Euro-American lineage which could potentially be attributed to total disruption of
methylation in the CCCAG motif but partial loss in a partner motif. Through a
genomic andmethylome comparative analysis with a global sample of sixteen, we report
previously unknown mutations affecting the pks15/1 locus in L6 isolates. We confirm
that methylation inMtb is lineage specific although some unresolved issues still remain.
Subjects Genomics, Microbiology, Molecular Biology, Infectious Diseases
Keywords Mycobacterium tuberculosis, DNA methylation, Single Molecule Real Time Sequencing,
Malawian Mtb clinical isolates, Motif
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INTRODUCTION
Mycobacterium tuberculosis (Mtb) is the causative agent of Tuberculosis (TB), infecting
about 1.7 billion people with 5–10% disease development rate in their lifetime (WHO,
2020). Although, Mtb strains exhibit >99% genomic homology (Hershberg et al., 2008),
virulence heterogeneity has been observed. The Beijing strain is associated with increasing
multidrug resistant TB (MDR-TB) (Cowley et al., 2008; Van der Spuy et al., 2009) whereas
the East African Indian (EAI) lineage has been associated with lower rates of transmission
compared to other lineages (Albanna et al., 2011). Similarly, the Euro-American lineage is
the most geographically successful strain (Gagneux & Small, 2007) but specific associated
mechanisms supporting this success remain unknown. The Mtb genome consists
of uniformly distributed high GC content (>60%) with minimal non-native DNA
incarcerations. Approximately 10% of the total coding potential contains polymorphic
guanine-cytosine repetitive sequences (PGRS) (Cole, 2002; Grover et al., 2018) which
encode two unrelated families of acidic glycine-rich proteins- proline-glutamic acid (PE)
and proline-proline glutamic acid (PPE). Specific functions of these genes and their
proteins remain unclear. However, proteins have been reported in the cell wall and the cell
membrane, playing roles in antigenic diversity, immune evasion and virulence (Fishbein et
al., 2015; Phelan et al., 2016), leading to phenotypic differences. Phenotypic heterogeneity
in Mtb has been associated with epigenetic inheritance (Balaban et al., 2004) and the most
common epigenetic mechanism inMtb is DNA methylation (Casadesus & Low, 2006; Shell
et al., 2013). A few studies have characterized the Mtb methylome and revealed three 6-
methyladenine (m6A)motifs and their cognatemethyltransferases (Mtases),MamA,MamB
andHsdM respectively (Shell et al., 2013; Zhu et al., 2015). Using Pacific Biosciences Single
Molecule Real Time (SMRT) sequencing, two studies have recently shown that specific
mutations in the Mtases lead to loss of Mtase activity and may play a role in evolution
of Mtb (Zhu et al., 2015; Phelan et al., 2018). At present the methylome of Mtb has not
been completely characterized, neither has any resulting information been correlated with
phenotypic heterogeneity observed in TB patients. Understanding the complete biology
of Mtb will aid in developing strategies for reducing the Mtb treatment duration from the
standard 6 months.
We present characterization of methylomes of 18Mtb isolates from patients in Blantyre,
Malawi. This work presents the largest number ofMtb genomes from a single location to be
completed in a single study using Single Molecule Real Time (SMRT) sequencing to date.
We confirm three confident sequence motifs inMtb including the strain specific mutations
responsible for loss of Mtase activity in Mtb. Additionally, for the first time we report the
complete loss of methylation courtesy of a novel mutation C758T (S253L) in Indo-oceanic
lineage (L1). We further report of a novel missense mutation G454A (G152S) in theMamA
gene of Euro-American lineage which could potentially be attributed to total disruption
of methylation in the CTCCAG motif but partial loss in a partner motif. Through a
genomic and methylome comparative analysis with a global sample of 16 samples we
report previously unreported mutations affecting the pks15/1 locus in L6 isolates.
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MATERIALS AND METHODS
Sample collection
Frozen archived clinical isolates from a parent previous prospective cohort study, Studying
Persistence and Understanding Tuberculosis in Malawi (S.P.U.T.U.M) (Sloan et al.,
2015) for which ethical approval had been obtained from the College of Medicine
Ethics Committee, University of Malawi (P.01/10/855) were characterized. These were
from patients aged 16–65 years old presenting with bacteriologically culture confirmed
pulmonary Mtb between June 2010 and December 2011 at Queen Elizabeth Central
Hospital in Blantyre, Malawi from whom prior informed consent had been obtained under
the SPUTUM study. Out of a total of 133 Mtb positive isolates, 18 were selected based on
which isolates were the first to be successfully revived from frozen state and used in this
study.
Bacterial growth conditions
All experiments involving Mtb were performed in a Biosafety Level (BSL) 3 Laboratory,
University ofMalawi-College ofMedicine/Malawi LiverpoolWelcome Trust (CoM/MLW)
TB laboratory and at Liverpool School of Tropical Medicine following Standard Operating
Procedures (SOPs). All reagents used were from Sigma-Aldrich unless otherwise stated.
For liquid culture, strains were grown in Middlebrook 7H9 broth base supplemented
with oleic acid, albumin, dextrose and catalase (OADC) and an antibiotic mixture of
polymyxin B, amphotericin B, nalidixic acid, trimethoprim and azlocillin (PANTA). Tubes
were incubated in a BACTEC MGIT 960 instrument at 37 ◦C and monitored once a
week for possible growth for up to eight weeks. Isolates used in the study were from
a previous study for which ethics approval had previously been granted by the College
of Medicine Ethics Committee (COMREC), University of Malawi (Sloan et al., 2015).
Solid culture inoculation was done on Lowenstein-Jensen (LJ) slopes following laboratory
SOP. Cultures were grown to mid-log phase and harvested at ∼7th week and used for
DNA isolation. Mtb was confirmed using both the BD MGIT TBC ID test device (Becton
Dickinson, Maryland U.S.A) following manufacturer’s instructions and Ziehl Neelsen
(ZN) staining for acid fast bacilli (AFB).
DNA extraction
Genomic DNA was isolated using the traditional Cetyltrimethylammonium bromide
(CTAB) method as previously described (Somerville et al., 2005). Extracted DNA
was quantified using Qubit 3.0 fluorometer (Life Technologies, USA) according to
manufacturer’s instructions and DNA purity was determined on a NanoDrop ND-1000
Spectrophotometer V3.7 (Thermo Scientific, Wilmington U.S.A) following manufacturer’s
instructions. DNA purity was checked at absorbance 260 nm and 280 nm by calculating a
ratio of A260/A280. DNA quality was analyzed on 1.5% Agarose Gel electrophoresis and
visualized under UV light following ethidium bromide staining.
Genotyping of Mtb Isolates
Genotyping of the isolates was done at the Liverpool School of Tropical Medicine, United
Kingdom. Lineage specific deletions were detected using a singleplex PCR based method
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with specific oligonucleotide primers targeting the regions of difference RD239, RD105
and RD750. PCR reactions were performed as documented in our previous publication
(Ndhlovu et al., 2019).
DNA sequencing
Purified genomic DNA libraries were sequenced at the Centre for Genomic Research
(CGR), Institute of Integrative Biology, University of Liverpool, United Kingdom. DNA
libraries were purified with 1x cleaned AMPure beads (Agencourt) and the quantity and
quality was assessed using the Qubit and NanoDrop assays respectively. In addition, the
Fragment Analyzer using a high sensitivity genomic kit (Advanced Analytical Technologies,
Inc.) was used to determine the average size of the DNA and the extent of degradation.
DNA was treated with Exonuclease V11 at 37 ◦C for 15 min. The ends of the DNA were
repaired as described by the manufacturer (Pacific Biosciences, Menlo Park, CA, USA).
The sample was incubated for 20 min at 37 ◦C with DNA damage repair mix supplied in
the SMRTbell library kit (Pac Bio). This was followed by a 5-minute incubation at 25 ◦C
with end repair mix. DNA was cleaned using 0.5× AMPure and 70% ethanol washes.
DNA was ligated to adapter overnight at 25 ◦C. Ligation was terminated by incubation
at 65 ◦C for 10 min followed by exonuclease treatment for 1 h at 37 ◦C. The SMRTbell
library was purified with 0.5x AMPure beads. The library was size selected with 0.75%
blue pippin cassettes in the range 7,000–20,000 bp. The recovered fragments were damage
repaired again. The quantity of library and therefore the recovery was determined by Qubit
assay and the average fragment size determined by Fragment Analyzer. SMRTbell library
was annealed to sequencing primer at values predetermined by the Binding Calculator
(PacBio) and a complex made with the DNA polymerase (P6/C4 chemistry). The complex
was bound to Magbeads and this was used to set up the required number of SMRT cells for
the project (two for each sample). Sequencing was performed on Pacific Biosciences RSII
sequencing system (Pacific Biosciences, Menlo Park, CA, USA) using 360-minute movie
times per cell, yielding ∼300x average genome coverage.
Bioinformatics analysis
Generated longPacbio readswere analyzedusing theRS_Modification_and_Motif_Analysis.1
protocol as part of SMRT analysis in SMRT Portal (version 2.2.0). To increase the
robustness of our analysis, we included previously published Mtb methylation study
Pacbio data (Bioproject: PRJEB21888) (Phelan et al., 2018) and conducted both genomic
and methylation comparisons of the two datasets. Although Bioproject PRJEB21888 had
18 genomes, we could only access 16 and these were used in our analysis. However, we
evaluated PRJEB21888 sequences using SMRT Portal (version 5.1.0). Reads were mapped
using the Basic Local Alignment with Successive Refinement (BLASR) (Chaisson & Tesler,
2012) algorithm within the SMRT portal. Strain specific genomes were generated by
mapping the reads to the reference genome (H37Rv) using Quiver tool. Standard settings
were used to detect base modifications and methylation motifs in the strain’s genome.
Inter-pulse duration (IPD) ratio (observed vs expected) was measured for the modification
detection (Zhu et al., 2015). Computational validation of our samples’ lineages and lineage
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identification of PRJEB21888 samples were done using TB-Profiler (Phelan et al., 0000).
Comparative analysis of pks15 (Rv2947c) gene was used to report lineages of the samples
specifically those from PRJEB21888. The MAFFT (version 7.310) (Katoh & Standley,
2013) was used to generate multiple sequence alignment of consensus sequences against
H37Rv reference. Following removal of the reference from the alignment, maximum
likelihood (ML) phylogeny was constructed for the remaining sequences using RaxML
(v8.2.12) GTR+0 model (Stamatakis, 2014) applying 1000 bootstrap iterations. Although
Mtb has a highly rigid and non-recombinogenic genome (>99% nucleotide identity), to
report diverse genomic regions among isolates, Gubbins (2.4.1) (Croucher et al., 2015) was
applied with the default parameters over previously generated alignment of 34 genomes
and earlier constructed ML phylogeny as an initial tree. Identified recombination hot spots
were plotted with phylogeny generated without hot spots, affected genes details and the
metadata using Phandango (Hadfield et al., 2018). Samples were clustered hierarchically
based on m6A IPD ratio pattern.
Multiple sequence alignment ofMtase genes (mamA,mamB, hsdM and hsdS) sequences
against the reference gene from H37Rv genome was used to identify potential mutations
responsible for loss of methylation. Comparative analysis of well characterized methylation
sites among samples were performed. Clustering of the samples based on their reported IPD
ratios at methylated sites was performed and compared with clustering in ML phylogeny.
RESULTS
Lineage analysis of Mycobacterium tuberculosis
Experimental (RD-PCR) and computational (TB-Profiler) outcomes on Malawian strains,
lineage identification was consistent revealing 3/18 (17%) L1 (Indo-Oceanic), 3/18 (17%)
L2 (East-Asian) and 12/18 (66%) L4 (Euro-American). De novo reporting of global
sample lineages (Phelan et al., 2018) (16 samples) using TB-Profiler revealed 3/16 L1(Indo-
oceanic), 2/16 L2 (East-Asian), 3/16 L4 (Euro-American), 2/16 L5 (West African 1 and
6/16 L6 (West African 2) (Table 1). Using intact pks15 (Rv2947c) gene, it was possible to
identify the 15/34 strains belonging to L4 in the combined dataset with a 7 bp deletion
(GGGCCGC) in the pks15/1 gene as previously documented (Constant et al., 2002;Gagneux
& Small, 2007). Additionally, pks15 (Rv2947c) could be used to assign lineages to the rest
of the samples. All L1 (6/34 strains) had a G1318C substitution and GGGCCGC insertion
while L2 (5/34) strains had a GGGCCGC insertion only. All L5 samples had a 9 bp deletion
(CGGTGCTGG,1097-1105), a distinct substitution A50G and an insertion GGGCCGC. A
L1, L5, L6 (G1318C substitution) and a L6 (1658 1 bp insertion of G), L1, L2, L5 (1658
7 bp insertion) (Fig. 1).
DNA methylation patterns
The m6A motifs present in more than 10 isolates were CACGCAG (820 sites), CTCCAG
(1947 sites), CTGGAG (1947 sites), GATN4RTAC (363 sites) and GTAYN4ATC (363
sites), Motifs CTCCAG and GATN4RTAC are paired with CTGGAG and GTAYN4ATC
respectively (Table S1). All L2 samples and one L6 sample (SAMEA104606027) lacked
methylation in CTGGAG/CTCCAG motif. One sample from L4 (ERS2711941) lacked
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Table 1 Lineages and sub-lineages of the samples reported by TB-Profiler using assembled genomic
sequences (ERS-Malawian and SAMEA-global samples).
Sample_ID Lineage Sub-lineage Sub-sub-lineage
ERS2711939 Lineage4 Lineage4.3 Lineage4.3.4
ERS2711940 Lineage4 Lineage4.3 Lineage4.3.4
ERS2711941 Lineage4 Lineage4.3
ERS2711942 Lineage4 Lineage4.3 Lineage4.3.4
ERS2711943 Lineage1 Lineage1.1 Lineage1.1.3
ERS2711944 Lineage4 Lineage4.3 Lineage4.3.4
ERS2711945 Lineage4 Lineage4.3 Lineage4.3.4
ERS2711946 Lineage4 Lineage4.3 Lineage4.3.4
ERS2711947 Lineage4 Lineage4.3 Lineage4.3.4
ERS2711948 Lineage1 Lineage1.1 Lineage1.1.3
ERS2711949 Lineage4 Lineage4.3 Lineage4.3.4
ERS2711950 Lineage4 Lineage4.5
ERS2711951 Lineage4 Lineage4.1.2




ERS2711956 Lineage1 Lineage1.1 Lineage1.1.3
SAMEA104606019 Lineage1 Lineage1.1 Lineage1.1.3
SAMEA104606020 Lineage1 Lineage1.1 Lineage1.1.3
SAMEA104606021 Lineage1 Lineage1.1 Lineage1.1.3
SAMEA104606022 Lineage5
SAMEA104606023 Lineage2 Lineage2.2 Lineage2.2.1
SAMEA104606024 Lineage4 Lineage4.3 Lineage4.3.4
SAMEA104606025 Lineage4 Lineage4.1 Lineage4.1.2
SAMEA104606026 Lineage6
SAMEA104606027 Lineage6
SAMEA104606028 Lineage2 Lineage2.2 Lineage2.2.1






methylation in the CTCCAG motif (Fig. 2A). The CTCCAG motif is methylated bymamA
Mtase (Shell et al., 2013). This L4 sample had a synonymous substitution at C216T and a
non-synonymous substitution at G454A resulting in G152S amino acid substitution in the
MamA gene. To our knowledge, this potentially methylation disrupting mutation has not
been previously reported. Multiple sequence comparison with the reference gene (Rv3263)
revealed all L2 samples as possessing a A809C (E270A) change as previously reported
(Shell et al., 2013; Zhu et al., 2015; Phelan et al., 2018) (including G1199C, W400S in only
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Figure 1 Lineage specifi.c sequence variants relative to the reference (H37Rv) gene pks15 (Rv2947c).
The pks15 gene from 34 samples was aligned against the reference (H37Rv) to display the differences at
four locations/ranges within the gene, discriminating four lineages L5 (A50G substitution), L5 (1097-1105
CGGTGCTGG deletion), L1, L5, L6 (G1318C substitution) and L6 (1658 1 bp insertion of G), L1, L2, L5
(1658 7bp insertion).
Full-size DOI: 10.7717/peerj.10432/fig-1
two samples). Consequently, all non-methylated L6 samples possessed a A1378G (A460T)
mutation in Rv3263 gene. The CACGCAG motif is methylated by the mamB Mtase (Zhu
et al., 2015; Phelan et al., 2018) and two of the six L1 samples (ERS2711948, ERS2711956)
lacked the mamB Mtase (Fig. 2A). Methylation in the rest of the samples was however
below 80% (range 56% - 79.6%) (Fig. 2C). Interestingly, all L1 samples (6) possessed
a C758T (S253L) mutation in the mamB gene (Rv2024c). This mutation has previously
been reported to be associated with partial loss of Mtase activity in L1 samples (Phelan
et al., 2018). This is the first time that mutation S253L is being associated with complete
loss of MamB Mtase function. Lineage 2 (ERS2711953) and L4 (ERS2711945) samples
possessed low methylation in CACGCAG motif (65% and 73% respectively) compared
to other samples from the same lineage (100%) despite absence of any specific mutations
in the mamB gene. Lineage specific mutation R289C (L6) and L452V (L5) did not affect
the mamB Mtase activity (Fig. 2C). However, non-lineage specific multiple variation was
reported at 3′ end. Motifs GATN4RTAC (363 sites) and GTAYN4ATC (363 sites) are
methylated by hsdM (Rv2756c) and hsdS (Rv2761c) genes (Zhu et al., 2015; Phelan et al.,
2018). Although one L1 sample (ERS2711956) lacked methylation in either motif the other,
(ERS2711948) was methylated at GTAY N4ATC only (Fig. 2A). The hsdM gene sequences
were identical for all L1 samples and no 5′-upstream alterations (300 bp) were reported.
All the L4 samples lacking GATN4RTAC/GTAYN4ATC methylation had mutations at
T917C resulting in L306P amino acid change in hsdM gene and G74T resulting in G25V
amino acid change in hsdS gene. While the T917C (L306P) mutation was previously
associated with loss of methylation (Shell et al., 2013; Zhu et al., 2015; Phelan et al., 2018),
the G74T(G25V) mutation in hsdS gene has not been previously reported. The distribution
of lineage specific motif methylation is shown in Fig. 2B and Fig. 2D. High variability in
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Figure 2 Methylation summary. (A) Distribution of methylated samples in each lineage for the motifs.
(B) Distribution of samples with methylated motifs in each lineage. (C) Methylation efficiency in samples
for each motif. (D) Methylation efficiency by motif in each lineage (numbers in parenthesis after the motif
represent total number of sites with that motif).
Full-size DOI: 10.7717/peerj.10432/fig-2
methylated motifs was observed in ‘‘modern’’ strains (L2/L4) defined by a conserved TbD1
genomic region while methylation was largely uniform in ‘‘ancient’’ strains (L5/L6) with
a deleted TbD1 genomic region, with all the detected motifs being methylated (Figs. 2A
and 2B). However, L1 (an ancient strain) was found to have the greatest variability of all
(standard deviation >0.2 with the rest of the samples being <0.2). The high variability in
L1 was a result of a few global samples clustering separately as opposed to the Malawian
samples. In summary L4 isolates were methylated at a higher frequency for all three motifs
than the rest of the isolates (Figs. 2A and 2B) and a higher fraction of modified motifs
(Figs. 2C and 2D).
Methylation efficiency among lineages
Among the samples having methylation in major motifs, most reported methylation
efficiency of higher than 82% (Fig. 2C, Table S1). Lineage 4 sample (ERS2711941) reported
58%methylation forCTGGAGmotif but lackedmethylation on the partnermotif CTCCAG
while another L4 sample (ERS2711945) reported 69% and 79% methylation on CTGGAG
and CTCCAG respectively. Two L1 samples (ERS2711948, ERS2711956) reported
methylation of 27% and 36%, 43% and 51% for CTGGAG and CTCCAG respectively
but having no specific mutation in methylation conferring genes. Methylation distribution
within motifs for each sample is displayed in Fig. 2D. Lineage 1 sample (ERS2711948) was
methylated at 32% onmotif G TAYN4ATC, while L2 sample (ERS2711953) was methylated
at 48% and 49% on GATN4RTACmotif. Other samples with low efficiency were as follows:
ERS2711953 from L2 with 65% methylation efficiency and L1 samples SAMEA104606020,
SAMEA104606019, SAMEA104606021 and ERS2711943 with 71%, 80%, 75% and 56%
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Figure 3 Tanglegram of hierarchically clustered samples. Clustering was based on IPD and ML phy-
logeny. Samples are coloured based on lineages. Three samples clustered separately from their lineage.
Two L4 samples (ERS2711951 and SAMEA104606025) with L6 and L5 samples, respectively.
Full-size DOI: 10.7717/peerj.10432/fig-3
respectively on CACGCAGmotif (Fig. 2C and Fig. 2D). Interestingly, we found association
between low methylation efficiency for all motifs (in 4/18 samples) and low sequencing
coverage <50x compared to none in the rest >100x probably resulting from poor sample
quality.
Comparison of methylation within Mtb strains
The strain arrangements in the m6A IPD ratio based cladogram clusters and genome based
maximum likelihood (ML) phylogeny were compared (Fig. 3). The samples clustered
into four IPD based groups. However, in the ML phylogeny lineages formed distinct
clusters. One L6 sample (SAMEA104606027) having no CTGGAG/CTCCAGMtase activity
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Figure 4 Diversity of regions in different samples and lineages. displayed in alignment frame of the
diïňĂerent samples and lineages calculated with default Gubbins parameters. Regions of aïňĂected gene
locations in the alignment, the phylogeny of the 34 samples and the recombination events.
Full-size DOI: 10.7717/peerj.10432/fig-4
clustered as a L2 sample (Fig. 3). Two L4 samples (ERS2711951 and SAMEA104606025)
lacking methylation in GATN4RTAC and GTAYN4ATC motifs clustered as L6 samples
respectively (Fig. 3). Interestingly, the two L4 samples formed their own distinct cluster on
ML phylogenetic tree.
In the recombination hotspot analysis, 256 genes were reported to have been affected
(Fig. 4). Ninety-one well annotated genes were affected due to insertions/deletions (Indels)
varying in size from 1 to 36016pb affecting a large number of PPE family (21), PE-PGRS
family (25) and ESAT 6 (6) genes. Lineage specific recombination relative rate to mutation
ratio (r/m) reported as L1: 0.968310, L2:1.865780, L4:4.915385, L5:1.001656, L6:1.066062.
Stability of methylation within mycobacterium tuberculosis strains
It was important to investigate the effect of culture media on methylation patterns. Two
isolates (ERS2711943 and ERS2711952) were MGIT grown but their methylation patterns
did not appear distinct from samples of the same lineage on solid culture except that
‘‘CACGCAG’’ motif for ERS2711943 reported the lowest methylation in the L1 samples
and GATN4RTAC motif was detected as methylated in ERS2711943 only. No significant
difference could be established between liquid and solid culture isolates for methylated
motif CTGGAG (Fishers exact test p= 0.76). As formotif CACGCAG solid cultured isolates
were methylated at an average 76% while liquid cultures were methylated an average 97%.
It was found that liquid cultured isolates were significantly more methylated than solid
cultures (Fisher’s exact p= 0.02) for motif CACGCAG. It was observed that this difference
was as a result of sample ERS2711943 having low levels of methylation (56%) compared
to the other samples at >95%.
We next investigated methylation within the gene regions and promoter regions of
genes.
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Methylation within gene regions ranged between 49% to 51% in each strand and
there was no over representation of methylation by strand (Chi squared test with Yates
correction P = 0.44). On the other hand, methylation within promoter regions of genes
ranged from 37% to 62% by strand of the promoter methylation. Again there was no
significant statistical differences observed by strand (Fishers exact test P = 0.19) suggesting
growth media did not affectMtase activity.
DISCUSSION
Studies of Mtb DNA methylation using SMRT sequencing have previously focused on
strains originating from Hongkong (2) (Leung et al., 2017) L2, China (12) (Zhu et al.,
2015),L2–L4, L6, L8 and more recently a global sample that included Europe, Asia, West
Africa and SouthAfrica (16) (Phelan et al., 2018), L1-L2, and L4-L6. In our study the activity
of Mtase could be inactivated by four different mutations somewhat in a lineage specific
manner. Loss ofMamAMtase in L2 (Beijing) isolates was associated with a point mutation
A809C (E270A) reported previously (Shell et al., 2013). Interestingly, L2 (Beijing) strains
have a higher propensity to cause active disease and have been associated with increasing
drug resistance in some geographical areas (Cowley et al., 2008); (Van der Spuy et al., 2009).
A recent study however failed to establish a possible role of methylation in virulence of
Beijing strains (‘‘Computational characterisation of DNA methylomes in mycobacterium
tuberculosis Beijing hyper- and hypo-virulent strains’’). Similarly, absence ofMamBMtase
in two (L1) Indo-oceanic isolates could be attributed to a C758T (S253L) novel missense
mutation recently characterized elsewhere (Phelan et al., 2018) and confirmed in this study.
While this mutation was putatively found to lead to partial methylation (50–60%) in a
previous study, for the first time, we report that it could also lead to complete loss ofMtase
activity as two of our L1 isolates lacked methylation. It is still unknown whether the C758T
(S253L) mutation contributes to recent transmission of EAI6 family in L1(Duarte et al.,
2017). Lack ofHsdM methylation in L4 could be attributed to the C917T (P306L) mutation
which was present in 11/12 Malawian isolates. These results are consistent with previous
studies which seem to suggest that the P306L mutation is very common in L4 strains
(Shell et al., 2013; Zhu et al., 2015). Lineage 4 isolates have the highest global prevalence
than any other lineage and more studies will be required to establish whether loss of HsdM
methylation could be associated with this global success. If indeedHsdMMtase is disrupted
by this mutation in L4, it remains intriguing how some L1 isolates could lose HsdM Mtase
in absence of anymutation in the hsdM gene. The novel missensemutation G454A (G152S)
could be attributed to total disruption ofmethylation in the CTCCAGmotif and partial loss
in the partner motif CTGGAG. Overall the higher occurrence of methylation disrupting
mutations in L2 and L4 (modern strains) compared to L1, L5 and L6 (ancient strains)
is suggestive of an evolutionary adaptation of these strains. The pks15/1 locus appears
to distinguishes L5 isolates using 9 bp (CGGTGCTGG) deletion, a distinct substitution
A50G and an insertion GGGCCGC while L6 isolates could also be classified using a 6bp
(GGGCCGC). The pks15/1 locus therefore a potential valuable marker for identifying L5
and L6 isolates. These two lineages are localized to west Africa and these distinct genetic
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markers could help explain this regional restriction. The fact that our sequenced isolates
were selected based on the first to be revived from frozen state may have resulted in a
sampling bias of selecting a subpopulation with a particular methylation pattern. It has
previously been demonstrated that methylation plays a key role in the growth ofMtb under
discrete microenvironments (Shell et al., 2013). Based on this, our results on methylation
patterns should be taken with caution as we have not included those samples that revive
slowly. The large number of genomic re-arrangements observed in cell wall component
genes PPE, PE-PGRS and ESAT-6 is evidence of the large variations that could potentially
explain strain/lineage specific propensity to cause and transmit disease. Additionally, the
high lineage specific recombination relative rate to mutation ratio observed in ‘‘ancient’’
strains (L1, L5 and L6) of∼1 compared to ‘‘modern’’ strains (L2 and 4) of >2 may explain
adaptation of strains to specific host populations and propensity to cause active disease.
Complete characterization of DNA methylation in Mtb could provide clues to some
of the clinical phenotypes which have been associated with strain and lineage variation.
Overall this study shows the potential of SMRT sequencing long reads to aid in better
understanding the complete biology of Mycobacterium tuberculosis by resolving repetitive
regions of the genome and elucidating the complete methylome of the pathogen. The
high frequency of Mtase disrupting mutations in Mtb could point to a competitive fitness
advantage such as immune evasion or even persistence. These sequences from Malawi
could serve as references in future Mtb methylome studies. This study is limited by the
fact that we could not establish via experimentation the direct association between specific
mutations and loss of Mtase activity. To better understand the complete impact of DNA
methylation within specific strains and lineages, subsequent studies will need to integrate
transcriptomic and proteomic data to methylomes.
CONCLUSIONS
We conclude that DNA methylation is lineage specific although some unresolved issues
still remain. Loss or absence of methylation may be used as a form of competitive fitness
advantage by clinical Mycobacterium tuberculosis isolates.
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